The prevalence of prostate cancer (PCa) in men is increasing worldwide owing to the aging population and the widespread screening for prostate-specific antigen (PSA); these factors have resulted in PCa having the highest recorded morbidity rate among all male-related malignancies [1]. This evidence concerns the gene KLK3 and prostate cancer.